Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124159) titled 'The efficacy of oliceridine combined with remimazolam in percutaneous vertebroplasty for elderly patients with frailty' on May 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University People's Hospital, Qingdao
Condition:
Thoracolumbar compression fracture
Intervention:
Intervention group:oliceridine combined with remimazolam (intervention group): Intravenously inject 1mg of orselenide when turning over
at the beginning of surgery, slowly inject 0.05mg/kg of remazolam intravenously, and then continuously pump 0.1mg/kg/h of remazolam intravenously
Recruitment Status: Not...